NADclinic Group and Geneva College of Longevity Science Announce Education Collaboration
NADclinic Group and the Geneva College of Longevity Science have entered an educational collaboration focused on clinician training in longevity and performance medicine.
Wellness Interviews
♾️
Wellness Interviews ♾️
LONDON and GENEVA, July 25, 2026, (WELLNESS INTERVIEWS) -- NADclinic Group and the Geneva College of Longevity Science have announced an educational collaboration that will provide clinicians in the NADclinic network with access to postgraduate and professional education in longevity science, preventive longevity medicine, and performance medicine.
The collaboration will include access to Geneva College of Longevity Science programs for appropriately licensed healthcare professionals affiliated with NADclinic Group.
The organizations also plan to hold webinars, clinical education sessions, masterclasses, and other educational activities focused on evidence-based practice, regulatory awareness, and clinical responsibility.
One of the available educational pathways is the Postgraduate Diploma in Peptide Therapeutics, led by Dr. Dean Berman. The online, self-paced program is intended for physicians, pharmacists, and other healthcare professionals.
According to the college, the program includes 28 modules, approximately 80 contact hours, and an expected duration of 12 weeks. It carries 10 European Credit Transfer and Accumulation System credits and concludes with a capstone case study.
The collaboration will also support PHI Peptides, a clinician-led longevity and performance medicine platform developed by NADclinic Group. The platform provides practitioner education, clinical guidance, and access pathways for licensed healthcare professionals.
“Longevity and performance medicine are moving quickly. That is exciting, but it also means the clinical education layer has to mature just as quickly. Our partners are asking better questions, patients are becoming more informed, and the industry has to move beyond noise into knowledge, structure and responsible practice. GCLS has built a serious academic platform for longevity education, and we are particularly excited by the work of Dr Dean Berman and the wider team in advancing education across emerging areas of longevity and performance medicine. For NADclinic, this collaboration is about giving our clinical partners access to better education, stronger frameworks and a more confident understanding of how advanced interventions can be delivered safely, responsibly and effectively. This is particularly important as we introduce PHI Peptides, our new clinician-led longevity and performance medicine platform. PHI has been built around the belief that access to emerging therapeutics must be supported by education, governance and responsible clinical pathways. The future of this field will not be defined by products alone. It will be defined by the infrastructure around them: education, governance, protocols, supply-chain integrity, patient journeys and outcomes,” said Iain De Havilland, Founder and Chief Executive Officer of NADclinic Group.
“Longevity medicine is moving from isolated interventions towards an integrated clinical discipline grounded in prevention, evidence and responsible implementation. Education is fundamental to that transition. We are delighted to collaborate with NADclinic to support clinicians with educational pathways that strengthen clinical decision-making and ultimately improve patient care. This collaboration between our institutions reflects the increasing global demand for structured clinician education and trusted clinical infrastructure as longevity medicine expands across Europe, the Middle East and Asia,” said Professor Dominik Thor, President of the Geneva College of Longevity Science.
NADclinic Group is a longevity and performance medicine organization that works with licensed clinicians, physicians, medical spas, professional sports organizations, and healthcare partners. Its services include clinician education, diagnostics, NAD+ therapies, and other longevity medicine programs.
The Geneva College of Longevity Science is a Switzerland-based higher education institution that provides postgraduate and professional education in longevity science for physicians and healthcare professionals.
For more information, visit www.nadclinic.com or www.gcls.study.
Source: NADclinic Group
